Protein detail
EZRI
Ezrin (Cytovillin) (Villin-2) (p81)
Protein symbol EZRI | UniProt ID | EVMP score 0.50 |
Frequency 2 | Transmembrane count | Protein classification Cancer-related genesPlasma proteinsPredicted intracellular proteins |
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Ezrin (Cytovillin) (Villin-2) (p81)
Protein Class
Cancer-related genesPlasma proteinsPredicted intracellular proteins
Protein Function
- Cancer-related genes:Mutated cancer genes
- Cancer-related genes:Candidate cancer biomarkers
- Predicted intracellular proteins
Ensembl
Entrez Gene Symbol
Gene Synonym
VIL2
Gene Description
Ezrin
Chromosome
6
Position
158765741-158819368
Frequency
2
EVMP Score
0.50
Fluorescence & Localization
Secretome LocationSecreted in other tissuesSecretome FunctionDevelopmental protein
Function & Pathway
Protein Function
- Cancer-related genes:Mutated cancer genes
- Cancer-related genes:Candidate cancer biomarkers
- Predicted intracellular proteins
Cellular Component
- GO:0001650 fibrillar center
- GO:0001726 ruffle
- GO:0001772 immunological synapse
- GO:0001931 uropod
- GO:0005615 extracellular space
- GO:0005737 cytoplasm
- GO:0005768 endosome
- GO:0005829 cytosol
- GO:0005884 actin filament
- GO:0005886 plasma membrane
- GO:0005902 microvillus
- GO:0005903 brush border
- GO:0005912 adherens junction
- GO:0005925 focal adhesion
- GO:0015629 actin cytoskeleton
- GO:0016020 membrane
- GO:0016323 basolateral plasma membrane
- GO:0016324 apical plasma membrane
- GO:0030175 filopodium
- GO:0030863 cortical cytoskeleton
- GO:0031528 microvillus membrane
- GO:0031982 vesicle
- GO:0032587 ruffle membrane
- GO:0032991 protein-containing complex
- GO:0036064 ciliary basal body
- GO:0042995 cell projection
- GO:0044853 plasma membrane raft
- GO:0045177 apical part of cell
- GO:0048471 perinuclear region of cytoplasm
- GO:0070062 extracellular exosome
- GO:0071944 cell periphery
Molecular Function
- GO:0003723 RNA binding
- GO:0003779 actin binding
- GO:0005515 protein binding
- GO:0008017 microtubule binding
- GO:0019904 protein domain specific binding
- GO:0034236 protein kinase A catalytic subunit binding
- GO:0034237 protein kinase A regulatory subunit binding
- GO:0042802 identical protein binding
- GO:0044548 S100 protein binding
- GO:0045296 cadherin binding
- GO:0050839 cell adhesion molecule binding
- GO:0051015 actin filament binding
- GO:0051018 protein kinase A binding
- GO:0051117 ATPase binding
- GO:0097718 disordered domain specific binding
Biological Process
KEGG
- hsa04517 IgSF CAM signaling
- KEGG:hsa04530 Tight junction
- KEGG:hsa04670 Leukocyte transendothelial migration
- KEGG:hsa04810 Regulation of actin cytoskeleton
- KEGG:hsa04971 Gastric acid secretion
- KEGG:hsa05130 Pathogenic Escherichia coli infection
- KEGG:hsa05205 Proteoglycans in cancer
- KEGG:hsa05206 MicroRNAs in cancer
Reactome
Mediation Categories
Adhesion and uptake mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence
Enzyme-Mediated Modification
39 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| EZR | S1PR2 | O95136 | T | 567 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:23629860 |
| EZR | ROCK2 | O75116 | T | 567 | phosphorylation | KEASparser_ProtMapperProtMapper | ProtMapper:20737283KEA:9456324 |
| EZR | EGF | P01133 | Y | 146 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:26936397ProtMapper:28603065 |
| EZR | EGF | P01133 | Y | 354 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:26936397 |
| EZR | SYK | P43405 | Y | 354 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:28306714ProtMapper:23338238 |
| EZR | SYK | P43405 | Y | 424 | phosphorylation | REACH_ProtMapperSparser_ProtMapperProtMapper | ProtMapper:28306714 |
| EZR | BCR | P11274 | Y | 354 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:25746045ProtMapper:23338238 |
| EZR | CD81 | P60033 | Y | 354 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:23338238 |
| EZR | CDK5R1 | Q15078 | T | 235 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:16510591 |
Page 4 of 4Previous
Ligand-Receptor Signaling
25 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| receptor | receptor | CellTalkDB | No | Yes | No | No | No |
| receptor | receptor | LRdb | No | Yes | No | No | No |
| receptor | receptor | OmniPath | No | Yes | No | No | No |
| extracellular | extracellular | OmniPath | No | No | No | No | No |
| intracellular | intracellular | LOCATE | No | No | No | No | No |
| intracellular | intracellular | ComPPI | No | No | No | No | No |
| intracellular | intracellular | GO_Intercell | No | No | No | No | No |
| intracellular | intracellular | UniProt_location | No | No | No | No | No |
| intracellular | intracellular | OmniPath | No | No | No | No | No |
| cell_surface_ligand | cell_surface_ligand | CellPhoneDB | Yes | No | No | No | No |
Page 1 of 3Next
Regulatory Interaction Network
18 records.
| Source Protein Symbol | Source UniProt ID | Target Protein Symbol | Target UniProt ID | Is Directed | Is Stimulation | Is Inhibition | Database | References |
|---|---|---|---|---|---|---|---|---|
| ROCK1 | Q13464 | EZRI | P15311 | Yes | Yes | No | HPRD_MIMPSIGNORProtMapperHINTPhosphoSite_KEAphosphoELM_KEAHPRDWangPhosphoSite_ProtMapperphosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetPhosphoPointKEAHPRD_KEAphosphoELMSIGNOR_ProtMapperAdhesomeACSNHPRD-phos | ACSN:10047517Adhesome:9856983ACSN:8522586ACSN:8527459HINT:11387207Adhesome:19386264ACSN:12045227ProtMapper:11387207ACSN:7579708HPRD-phos:11387207phosphoELM:19255442ACSN:9287351HPRD:11387207KEA:10970850KEA:11387207HPRD-phos:10970850HPRD:10970850Adhesome:19255442KEA:14504278ProtMapper:10970850ACSN:10970850ProtMapper:19386264phosphoELM:19386264SIGNOR:19386264ACSN:12802084KEA:15843435HINT:10970850phosphoELM:10970850ACSN:12778124Adhesome:11387207KEA:15531580Adhesome:10970850 |
| TP4A3 | O75365 | EZRI | P15311 | Yes | No | Yes | SIGNOR_ProtMapperSIGNORProtMapperDEPOD | DEPOD:18078820SIGNOR:18078820ProtMapper:18078820 |
| STK26 | Q9P289 | EZRI | P15311 | Yes | Yes | No | WangphosphoELM_MIMPPhosphoSite_MIMPMIMPNCI-PID_ProtMapperHPRD_MIMPiPTMnetSIGNORProtMapperRLIMS-P_ProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSite_ProtMapper | ProtMapper:32742458SIGNOR:19386264ProtMapper:19386264 |
| AKT2 | P31751 | EZRI | P15311 | Yes | Yes | No | WangBEL-Large-Corpus_ProtMapperphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetPhosphoPointSIGNORProtMapperPhosphoSite_KEAKEAphosphoELM_KEAphosphoELMSIGNOR_ProtMapperPhosphoSite_ProtMapper | ProtMapper:15531580KEA:14504278SIGNOR:15531580KEA:15843435KEA:10970850KEA:11387207phosphoELM:15531580KEA:15531580 |
| RHOA | P61586 | EZRI | P15311 | Yes | Yes | No | WangAdhesomeiPTMnetSIGNORProtMapperSIGNOR_ProtMapperREACH_ProtMapper | ProtMapper:31775562ProtMapper:35267019ProtMapper:20737283SIGNOR:35267019Adhesome:15659383 |
| EZRI | P15311 | FES | P07332 | Yes | Yes | No | DOMINOSIGNORHINTIntActSPIKE_LCLit-BM-17 | SPIKE_LC:18046454Lit-BM-17:18046454HINT:18046454DOMINO:18046454SIGNOR:18046454IntAct:18046454HINT:35613471 |
| CDK5 | Q00535 | EZRI | P15311 | Yes | Yes | No | Sparser_ProtMapperMIMPHPRD_MIMPiPTMnetPhosphoPointSIGNORProtMapperELMHPRDPhosphoSite_KEAKEARLIMS-P_ProtMapperphosphoELM_KEAHPRD_KEASIGNOR_ProtMapperREACH_ProtMapperHPRD-phos | KEA:12769842ProtMapper:28702704HPRD-phos:12769842ProtMapper:12769842HPRD:12769842ProtMapper:16510591ProtMapper:20308985ELM:12769842SIGNOR:12769842 |
| KAPCA | P17612 | EZRI | P15311 | Yes | Yes | No | PhosphoSite_MIMPMIMPiPTMnetProtMapperPhosphoSitePhosphoSite_ProtMapper | PhosphoSite:12840026 |
Page 2 of 2Previous
Protein Complex Composition
Isolation & Detection Technology
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential Ultracentrifugation | Mass spectrometry | 1 | 38014595 |
Sequence, Structure & Domains
Sequences
Length
586
Mass
69,413
Sequence
MPKPINVRVTTMDAELEFAIQPNTTGKQLFDQVVKTIGLREVWYFGLHYVDNKGFPTWLKLDKKVSAQEVRKENPLQFKFRAKFYPEDVAEELIQDITQKLFFLQVKEGILSDEIYCPPETAVLLGSYAVQAKFGDYNKEVHKSGYLSSERLIPQRVMDQHKLTRDQWEDRIQVWHAEHRGMLKDNAMLEYLKIAQDLEMYGINYFEIKNKKGTDLWLGVDALGLNIYEKDDKLTPKIGFPWSEIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRINKRILQLCMGNHELYMRRRKPDTIEVQQMKAQAREEKHQKQLERQQLETEKKRRETVEREKEQMMREKEELMLRLQDYEEKTKKAERELSEQIQRALQLEEERKRAQEEAERLEADRMAALRAKEELERQAVDQIKSQEQLAAELAEYTAKIALLEEARRRKEDEVEEWQHRAKEAQDDLVKTKEELHLVMTAPPPPPPPVYEPVSYHVQESLQDEGAEPTGYSAELSSEGIRDDRNEEKRITEAEKNERVQRQLLTLSSELSQARDENKRTHNDIIHNENMRQGRDKYKTLRQIRQGNTKQRIDEFEAL
3D Structural Models
Turn
139..141; 144..149; 179..181; 199..202
Helix
26..37; 42..44; 65..67; 89..92; 96..111; 119..134; 155..159; 165..178; 184..196; 242..244; 274..295; 520..523; 525..539; 544..546; 549..559; 564..571; 576..585
Beta Strand
5..10; 15..20; 45..51; 56..58; 61..64; 74..84; 204..210; 215..221; 224..229; 233..235; 237..241; 245..251; 254..261; 267..270
3D Structure
X-ray crystallography (6)
Domain & Motif Annotations
Compositional Bias
308..341; Basic and acidic residues; 507..528; Basic and acidic residues; 530..539; Polar residues; 540..564; Basic and acidic residues
Motif
115..120; [IL]-x-C-x-x-[DE] motif
Coiled Coil
302..462
Domain (CC)
Has three main structural domains: an N-terminal FERM domain, a central alpha-helical domain and a C-terminal actin-binding domain.; DOMAIN: The FERM domain is organized in a clover-shaped structure that comprises three subdomains identified as F1 (residues 2-82), F2 (residues 96-198), and F3 (residues 204-296). In the active form, the subdomain F3 adopts two mutually exclusive conformational isomers where a row of four phenylalanine side chains (Phe250, Phe255, Phe267 and Phe269) must point in the same direction. In the autoinhibited form, the F3 subdomain interacts with the C-terminal domain (residues 516-586) and stabilizes the structure, selecting only one possible arrangement of phenylalanine side chains. The FERM domain mediates binding to membrane lipids and signaling molecules.; DOMAIN: The central alpha-helical domain is composed of two alpha helices (residues 326-406 and 417-466) connected by a linker. It protrudes from the FERM domain forming a coiled coil structure where the linker can have either a loop or a helix conformation. The monomer is predicted to form an intra-molecular helix-loop-helix coiled coil structure. Whereas the dimer adopts an elongated dumbbell-shaped configuration where continuous alpha helices from each protomer are organized in a antiparallel coiled coil structure that connect FERM:C-terminal domain swapped complex at each end. The dimer is predicted to link actin filaments parallel to the plasma membrane.; DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex.
Domain (FT)
2..296; FERM
Region
244..586; Interaction with SCYL3; 306..341; Disordered; 485..564; Disordered
Clinical Relevance
Disease Involvement
Cancer-related genes
Drugs
Interaction Protein
ENSG00000000457ENSG00000065054ENSG00000099812ENSG00000109062ENSG00000137710ENSG00000141522ENSG00000146648ENSG00000147065
Interaction Count
8
Interaction Dataset
intact_biogridintact_biogrid_bioplexbiogrid_opencell_bioplex